Cargando…

Impaired IFNγ-Signaling and Mycobacterial Clearance in IFNγR1-Deficient Human iPSC-Derived Macrophages

Mendelian susceptibility to mycobacterial disease (MSMD) is caused by inborn errors of interferon gamma (IFNγ) immunity and is characterized by severe infections by weakly virulent mycobacteria. Although IFNγ is the macrophage-activating factor, macrophages from these patients have never been studie...

Descripción completa

Detalles Bibliográficos
Autores principales: Neehus, Anna-Lena, Lam, Jenny, Haake, Kathrin, Merkert, Sylvia, Schmidt, Nico, Mucci, Adele, Ackermann, Mania, Schubert, Madline, Happle, Christine, Kühnel, Mark Philipp, Blank, Patrick, Philipp, Friederike, Goethe, Ralph, Jonigk, Danny, Martin, Ulrich, Kalinke, Ulrich, Baumann, Ulrich, Schambach, Axel, Roesler, Joachim, Lachmann, Nico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5768914/
https://www.ncbi.nlm.nih.gov/pubmed/29249666
http://dx.doi.org/10.1016/j.stemcr.2017.11.011
Descripción
Sumario:Mendelian susceptibility to mycobacterial disease (MSMD) is caused by inborn errors of interferon gamma (IFNγ) immunity and is characterized by severe infections by weakly virulent mycobacteria. Although IFNγ is the macrophage-activating factor, macrophages from these patients have never been studied. We demonstrate the generation of heterozygous and compound heterozygous (iMSMD-cohet) induced pluripotent stem cells (iPSCs) from a single chimeric patient, who suffered from complete autosomal recessive IFNγR1 deficiency and received bone-marrow transplantation. Loss of IFNγR1 expression had no influence on the macrophage differentiation potential of patient-specific iPSCs. In contrast, lack of IFNγR1 in iMSMD-cohet macrophages abolished IFNγ-dependent phosphorylation of STAT1 and induction of IFNγ-downstream targets such as IRF-1, SOCS-3, and IDO. As a consequence, iMSMD-cohet macrophages show impaired upregulation of HLA-DR and reduced intracellular killing of Bacillus Calmette-Guérin. We provide a disease-modeling platform that might be suited to investigate novel treatment options for MSMD and to gain insights into IFNγ signaling in macrophages.